![]() Proactive Investors UK |
AstraZeneca: ONGLYZA Receives Positive Opinion From CHMP
Wall Street Journal -These involved 4148 patients withtype 2 diabetes, including 3021 patients treated with saxagliptin. -Saxagliptin belongs to the class of dipeptidyl… Astra, Bristoldiabetesdrug recommended in EuropeReuters Bristoldiabetesdrug gets positive EU reviewBusinessWeek Bristol-Myers, AstraZeneca obtain positive opinion in Europe for…Trading Markets (press release) RTT News –The News Journal –Merinews all 51 news articles » |
Discussion
Comments are disallowed for this post.
Comments are closed.